Skip to main content
. 2021 Jul;559:100–110. doi: 10.1016/j.virol.2021.03.019

Fig. 5.

Fig. 5

Monocyte changes after ZIKV rechallenge.

Classical (CD14+, CD16-) (A-C), intermediate (CD14+, CD16+) (D-F), and non-classical (CD14low/-, CD16+) (G-I) monocytes were assessed for changes in frequency (A, D, G) and activation as measured by CD69 expression (B, E, H) and CD169 expression (C, F, I), after ZIKV rechallenge.